SMAD4 and neoplasm: In another similar study by Izeradjene et al, 2007 [47] on various molecular aspects on invasive adenocarcinoma of pancreas, it was revealed that KRASG12D tumors had higher chances of developing the SMAD4 haplo-insufficiency, which in turn leads to invasiveness of the tumor.